For many decades, scientists have been studying the effect of thyroid hormones in promoting cancer proliferation. Confusion and contradictions often arise in “cancer & thyroid” research reviews because the relationship between cancer and thyroid hormones is very complex. For example, a recent review of science since the 1940s attempted to reclassify research findings under poorly defined generalizations of “hypothyroidism,” “euthyroidism” or “hyperthyroidism” and variable “high T3” or “low T4” conditions (Krashin et al, 2019). Such reviews can muddy the science more than clarify it. Fortunately, Aleck Hercbergs and Paul J. Davis and colleagues have been at the forefront of research …
Category: Cancers
2018 study on T4 and T3 in breast cancer
Published August 2018, a new study of T4 and T3 hormones and obesity in relation to breast cancer risk found that higher levels of T4 hormone conferred greater risk, while higher T3 levels had a protective effect. The article Ortega-Olvera, C., Ulloa-Aguirre, A., Ángeles-Llerenas, A., Mainero-Ratchelous, F. E., González-Acevedo, C. E., Hernández-Blanco, M. de L., … Torres-Mejía, G. (2018). Thyroid hormones and breast cancer association according to menopausal status and body mass index. Breast Cancer Research : BCR, 20. Available online at PubMed Central https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085630/ Why it matters for thyroid patients too! The standard T4 (Levothyroxine / Synthroid) therapy produces T4 levels that …